Literature DB >> 28637129

Patient reported outcomes in GNE myopathy: incorporating a valid assessment of physical function in a rare disease.

Christina Slota1,2, Margaret Bevans3, Li Yang3, Joseph Shrader4, Galen Joe4, Nuria Carrillo1,5.   

Abstract

BACKGROUND: The aim of this analysis was to evaluate the psychometric properties of three patient reported outcome (PRO) measures characterizing physical function in GNE myopathy: the Human Activity Profile, the Inclusion Body Myositis Functional Rating Scale, and the Activities-specific Balance Confidence scale.
METHODS: This analysis used data from 35 GNE myopathy subjects participating in a natural history study. For construct validity, correlational and known-group analyses were between the PROs and physical assessments. Reliability of the PROs between baseline and 6 months was evaluated using the intra-class correlation coefficient model; internal consistency was tested with Cronbach's alpha.
RESULTS: The hypothesized moderate positive correlations for construct validity were supported; the strongest correlation was between the human activity profile adjusted activity score and the adult myopathy assessment endurance subscale score (r = 0.81; p < 0.0001). The PROs were able to discriminate between known high and low functioning groups for the adult myopathy assessment tool. Internal consistency of the PROs was high (α > 0.8) and there was strong reliability (ICC >0.62).
CONCLUSION: The PROs are valid and reliable measures of physical function in GNE myopathy and should be incorporated in investigations to better understand the impact of progressive muscle weakness on physical function in this rare disease population. Implications for Rehabilitation GNE myopathy is a rare muscle disease that results in slow progressive muscle atrophy and weakness, ultimately leading to wheelchair use and dependence on a caregiver. There is limited knowledge on the impact of this disease on the health-related quality of life, specifically physical function, of this rare disease population. Three patient reported outcomes have been shown to be valid and reliable in GNE myopathy subjects and should be incorporated in future investigations to better understand how progressive muscle weakness impacts physical functions in this rare disease population. The patient reported outcome scores of GNE myopathy patients indicate a high risk for falls and impaired physical functioning, so it is important clinicians assess and provide interventions for these subjects to maintain their functional capacity.

Entities:  

Keywords:  Psychometrics; activities of daily living; construct validity; hereditary inclusion body myopathy; quality of life; reliability

Mesh:

Year:  2017        PMID: 28637129      PMCID: PMC6166247          DOI: 10.1080/09638288.2017.1283712

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  58 in total

1.  An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene.

Authors:  A Broccolini; M Pescatori; A D'Amico; A Sabino; G Silvestri; E Ricci; S Servidei; P A Tonali; M Mirabella
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

2.  Functional reach: predictive validity in a sample of elderly male veterans.

Authors:  P W Duncan; S Studenski; J Chandler; B Prescott
Journal:  J Gerontol       Date:  1992-05

3.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients.

Authors:  D A Redelmeier; A M Bayoumi; R S Goldstein; G H Guyatt
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

4.  Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Philipp Yorck Herzberg; Pia Heussner; Friederike H A Mumm; Melanie Horak; Inken Hilgendorf; Stephanie von Harsdorf; Philipp Hemmati; Kathrin Rieger; Hildegard Greinix; Mathias Freund; Stephanie J Lee; Ernst Holler; Daniel Wolff
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-09       Impact factor: 5.742

Review 5.  A systematic review of the Human Activity Profile.

Authors:  Megan Davidson; Natalie de Morton
Journal:  Clin Rehabil       Date:  2007-02       Impact factor: 3.477

6.  Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium.

Authors: 
Journal:  Arch Phys Med Rehabil       Date:  1996-12       Impact factor: 3.966

7.  Is the functional reach test useful for identifying falls risk among individuals with Parkinson's disease?

Authors:  Andrea L Behrman; Kathye E Light; Sheryl M Flynn; Mary T Thigpen
Journal:  Arch Phys Med Rehabil       Date:  2002-04       Impact factor: 3.966

Review 8.  Interpreting patient-reported outcome results: US FDA guidance and emerging methods.

Authors:  Lori D McLeod; Cheryl D Coon; Susan A Martin; Sheri E Fehnel; Ron D Hays
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-04       Impact factor: 2.217

9.  Psychometric properties of the activities-specific balance confidence scale and the survey of activities and fear of falling in older women.

Authors:  Kristine M C Talley; Jean F Wyman; Cynthia R Gross
Journal:  J Am Geriatr Soc       Date:  2007-12-26       Impact factor: 5.562

10.  Two recurrent mutations are associated with GNE myopathy in the North of Britain.

Authors:  Amina Chaouch; Kathryn M Brennan; Judith Hudson; Cheryl Longman; John McConville; Patrick J Morrison; Maria E Farrugia; Richard Petty; Willie Stewart; Fiona Norwood; Rita Horvath; Patrick F Chinnery; Donald Costigan; John Winer; Tuomo Polvikoski; Estelle Healy; Anna Sarkozy; Teresinha Evangelista; Oksana Pogoryelova; Michelle Eagle; Kate Bushby; Volker Straub; Hanns Lochmüller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-02       Impact factor: 10.154

View more
  3 in total

Review 1.  GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.

Authors:  Nuria Carrillo; May C Malicdan; Marjan Huizing
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 2.  GNE myopathy: from clinics and genetics to pathology and research strategies.

Authors:  Oksana Pogoryelova; José Andrés González Coraspe; Nikoletta Nikolenko; Hanns Lochmüller; Andreas Roos
Journal:  Orphanet J Rare Dis       Date:  2018-05-02       Impact factor: 4.123

3.  Patient-driven initiatives for prioritizing drug discovery for rare diseases.

Authors:  Alok Bhattacharya; Sudha Bhattacharya
Journal:  Indian J Med Res       Date:  2019-03       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.